A PET [18F]altanserin study of 5-HT2A receptor binding in the human brain and responses to painful heat stimulation

NeuroImage

Volumn 44, Issue 3, 2009, Pages 1001-1007

  Kupers, Ron ^a   Frokjaer, Vibe G ^b   Naert, Arne ^a   Christensen, Rune ^a   Budtz Joergensen, Esben ^a   Kehlet, Henrik ^a   Knudsen, Gitte M ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALTANSERIN F 18; SEROTONIN 2A RECEPTOR; TRACER; UNCLASSIFIED DRUG; ALTANSERIN; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORINE; KETANSERIN; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BRAIN; CINGULATE GYRUS; COGNITION; FEMALE; FRONTAL CORTEX; HEAT; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORBITAL CORTEX; PAIN THRESHOLD; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BINDING; SENSORIMOTOR CORTEX; STIMULATION; BINDING SITE; METABOLISM; METHODOLOGY; PAIN; PATHOPHYSIOLOGY; SCINTISCANNING; TISSUE DISTRIBUTION;

ADULT; BINDING SITES; BRAIN; FEMALE; FLUORINE RADIOISOTOPES; HOT TEMPERATURE; HUMANS; KETANSERIN; MALE; PAIN; PAIN THRESHOLD; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RADIOPHARMACEUTICALS; RECEPTOR, SEROTONIN, 5-HT2A; TISSUE DISTRIBUTION;

EID: 57649165244     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2008.10.011     Document Type: Article

References (47)

1. Adams K.H., Pinborg L.H., Svarer C., Hasselbalch S.G., Holm S., Haugbøl S., Madsen K., Frøkjaer V., Martiny L., Paulson O.B., and Knudsen G.M. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables. NeuroImage 21 (2004) 1105-1113
2. Baliki M.N., Geha P.Y., Apkarian A.V., and Chialvo D.R. Beyond feeling: chronic pain hurts the brain, disrupting the default-mode network dynamics. J. Neurosci. 28 (2008) 1398-1403
3. Bardin L., Lavarenne J., and Eschalier A. Serotonin receptor subtypes involved in the spinal antinociceptive effect of 5-HT in rats. Pain 86 (2000) 11-18
4. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 4 (1961) 561-571
5. Beck A.T., Epstein N., Brown G., and Steer R.A. An inventory for measuring clinical anxiety: psychometric properties. J. Consult. Clin. Psychol. 56 (1988) 893-897
6. Boly M., Balteau E., Schnakers C., Degueldre C., Moonen G., Luxen A., Phillips C., Peigneux P., Maquet P., and Laureys S. Baseline brain activity fluctuations predict somatosensory perception in humans. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 12187-12192
7. Bushnell M.C., Duncan G.H., Hofbauer R.K., Ha B., Chen J.I., and Carrier B. Pain perception: is there a role for primary somatosensory cortex?. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 7705-7709
8. Cahir M., Ardis T., Reynolds G.P., and Cooper S.J. Acute and chronic tryptophan depletion differentially regulate central 5-HT1A and 5-HT 2A receptor binding in the rat. Psychopharmacology (Berl) 190 (2007) 497-506
9. Craig A.D. How do you feel? Interoception: the sense of the physiological condition of the body. Nat. Rev., Neurosci. 3 (2002) 655-666
10. De Luca-Vinhas M.C., Macedo C.E., and Brandão M.L. Pharmacological assessment of the freezing, antinociception, and exploratory behavior organized in the ventrolateral periaqueductal gray. Pain 121 (2006) 94-104
11. de Oliveira R.C., de Oliveira R., Ferreira C.M., and Coimbra N.C. Involvement of 5-HT(2) serotonergic receptors of the nucleus raphe magnus and nucleus reticularis gigantocellularis/paragigantocellularis complex neural networks in the antinociceptive phenomenon that follows the post-ictal immobility syndrome. Exp. Neurol. 201 (2006) 144-153
12. Derogatis L.R. SCL-90-R: Symptom Checklist-90-R. Administration, Scoring and Procedures Manual. 3rd ed. (1994), National Computer Systems, Minneapolis, Minnesota
13. Draganski B., Moser T., Lummel N., Gänssbauer S., Bogdahn U., Haas F., and May A. Decrease of thalamic gray matter following limb amputation. NeuroImage 3 (2006) 951-957
14. Frokjaer V.G., Mortensen E.L., Nielsen F.A., Haugbol S., Pinborg L.H., Adams K.H., Svarer C., Hasselbalch S.G., Holm S., Paulson O.B., and Knudsen G.M. Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biol. Psychiatry 63 (2008) 569-576
15. Garcia-Larrea L., and Peyron R. Motor cortex stimulation for neuropathic pain: from phenomenology to mechanisms. NeuroImage 37 Suppl 1 (2007) S71-S79
16. Geuze E., Westenberg H.G., Jochims A., de Kloet C.S., Bohus M., Vermetten E., and Schmahl C. Altered pain processing in veterans with posttraumatic stress disorder. Arch. Gen. Psychiatry 64 (2007) 76-85
17. Jakab R.L., and Goldman-Rakic P.S. Segregation of serotonin 5-HT2A and 5-HT3 receptors in inhibitory circuits of the primate cerebral cortex. J. Comp. Neurol. 417 (2000) 337-348
18. Harvey J.A. Role of the serotonin 5-HT(2A) receptor in learning. Learn Mem. 10 (2003) 355-362
19. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6 (1967) 278-296
20. Honda M., Uchida K., Tanabe M., and Ono H. Fluvoxamine, a selective serotonin reuptake inhibitor, exerts its antiallodynic effects on neuropathic pain in mice via 5-HT2A/2C receptors. Neuropharmacology 51 (2006) 866-872
21. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab. 27 (2007) 1533-1539
22. Kayser V., Elfassi I.E., Aubel B., Melfort M., Julius D., Gingrich J.A., Hamon M., and Bourgoin S. Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A-/-, 5-HT1B-/-, 5-HT2A-/-, 5-HT3A-/- and 5-HTT-/- knock-out male mice. Pain 130 (2007) 235-248
23. Kjørsvik A., Tjølsen A., and Hole K. Activation of spinal serotonin(2A/2C) receptors augments nociceptive responses inthe rat. Brain Res. 910 (2001) 179-181
24. Kulkarni B., Bentley D.E., Elliott R., Julyan P.J., Boger E., Watson A., Boyle Y., El-Deredy W., and Jones A.K. Arthritic pain is processed in brain areas concerned with emotions and fear. Arthritis Rheum. 56 (2007) 1345-1354
25. Lehner M., Taracha E., Turzyńska D., Sobolewska A., Hamed A., Kołomańska P., Skórzewska A., Maciejak P., Szyndler J., Bidziński A., and Płaźnik A. The role of the dorsomedial part of the prefrontal cortex serotonergic innervation in rat responses to the aversively conditioned context: behavioral, biochemical and immunocytochemical studies. Behav. Brain Res. 192 (Apr 16) (2008) 203-215
26. Lopez-Garcia J.A. Serotonergic modulation of spinal sensory circuits. Curr. Top. Med. Chem. 6 (2006) 1987-1996
27. Maddock R.J. The retrosplenial cortex and emotion: new insights from functional neuroimaging of the human brain. Trends Neurosci. 22 (1999) 310-316
28. 18F]-altanserin PET study. Eur. J. Nucl. Med. Mol. Imaging.
29. Martikainen I.K., Hirvonen J., Kajander J., Hagelberg N., Mansikka H., Någren K., Hietala J., and Pertovaaraa A. Correlation of human cold pressor pain responses with 5-HT(1A) receptor binding in the brain. Brain Res. 1172 (2007) 21-31
30. May A. Chronic pain may change the structure of the brain. Pain 137 (Apr 12) (2008) 7-15
31. Millan M.J. Descending control of pain. Prog. Neurobiol. 66 (2002) 355-474
32. Naert A.L., Kehlet H., and Kupers R. Characterization of a novel model of tonic heat pain stimulation in healthy volunteers. Pain 138 (2008) 163-171
33. Okamoto K., Imbe H., Kimura A., Donishi T., Tamai Y., and Senba E. Activation of central 5HT2A receptors reduces the craniofacial nociception of rats. Neuroscience. 147 (2007) 1090-1102
34. Petrovic P., and Ingvar M. Imaging cognitive modulation of pain processing. Pain 95 (2002) 1-5
35. 18F]altanserin-PET and the bolus/infusion approach. J. Cereb. Blood Flow Metab. 23 (2003) 985-996
36. Price D.D., McGrath P.A., Rafii A., and Buckingham B. The validation of visual analogue scales as ration scale measures for chronic and experimental pain. Pain 17 (1983) 45-56
37. Ringel Y., Drossman D.A., Leserman J.L., Suyenobu B.Y., Wilber K., Lin W., Whitehead W.E., Naliboff B.D., Berman S., and Mayer E.A. Effect of abuse history on pain reports and brain responses to aversive visceral stimulation: an FMRI study. Gastroenterology 134 (2008) 396-404
38. Rolls E.T., O'Doherty J., Kringelbach M.L., Francis S., Bowtell R., and McGlone F. Representations of pleasant and painful touch in the human orbitofrontal and cingulate cortices. Cereb. Cortex 13 (2003) 308-317
39. Roth B.L., Berry S.A., Kroeze W.K., Willins D.L., and Kristiansen K. Serotonin 5-HT2A receptors: molecular biology and mechanisms of regulation. Crit. Rev. Neurobiol. 12 (1998) 319-338
40. Schestatsky P., Kumru H., Valls-Solé J., Valldeoriola F., Marti M.J., Tolosa E., and Chaves M.L. Neurophysiologic study of central pain in patients with Parkinson disease. Neurology 69 (2007) 2162-2169
41. Schmahl C., Bohus M., Esposito F., Treede R.D., Di Salle F., Greffrath W., Ludaescher P., Jochims A., Lieb K., Scheffler K., Hennig J., and Seifritz E. Neural correlates of antinociception in borderline personality disorder. Arch. Gen. Psychiatry 63 (2006) 659-667
42. Schmidt-Wilcke T., Gänssbauer S., Neuner T., Bogdahn U., and May A. Subtle grey matter changes between migraine patients and healthy controls. Cephalalgia. 28 (2008) 1-4
43. Soleimannejad E., Semnanian S., Fathollahi Y., and Naghdi N. Microinjection of ritanserin into the dorsal hippocampal CA1 and dentate gyrus decrease nociceptive behavior in adult male rat. Behav. Brain Res. 168 (2006) 221-225
44. Stockmeier C.A., and Kellar K.J. In vivo regulation of the serotonin-2 receptor in rat brain. Life Sci. 38 (1986) 117-127
45. Svarer C., Madsen K., Hasselbalch S.G., Pinborg L.H., Haugbol S., Frokjaer V.G., Martiny L., Paulson O.B., and Knudsen G.M. MR-based automatic delineation of volumes of interest in human brain PET-images using probability maps. NeuroImage 24 24 (2005) 969-979
46. Van Steenwinckel J., Brisorgueil M.J., Fischer J., Vergé D., Gingrich J., Bourgoin S., Hamon M., Bernard R., and Conrath M. Role of spinal serotonin 5-HT2A receptor in 2′,3′-dideoxycytidine-induced neuropathic pain in the rat and the mouse. Pain 137 (Sep 19) (2007) 66-80
47. Witting N., Kupers R.C., Svensson P., and Jensen T.S. A PET activation study of brush-evoked allodynia in patients with nerve injury pain. Pain 120 (2006) 145-154